The landscape of dementia prognosis has progressed substantially with the advent of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-based tests that can detect Alzheimer's pathology several years in advance of indications emerge. Even though these technological advancements stand for remarkable development in being familiar with neurodegenerative https://johnp653rbl3.westexwiki.com/user